Cme Group annual shareholders’ equity
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group Shareholders’ Equity Growth & History (CME)
Cme Group's shareholders’ equity was $28.73B for fiscal 2025.
View full Cme Group company overviewCme Group annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $28.73B | $2.24B | +8.46% |
| 2024 | 2024-12-31 | $26.49B | −$251.0M | −0.94% |
| 2023 | 2023-12-31 | $26.74B | −$140.8M | −0.52% |
| 2022 | 2022-12-31 | $26.88B | −$520.6M | −1.90% |
| 2021 | 2021-12-31 | $27.40B | $1.05B | +3.98% |
| 2020 | 2020-12-31 | $26.35B | $192.2M | +0.73% |
| 2019 | 2019-12-31 | $26.16B | $194.0M | +0.75% |
| 2018 | 2018-12-31 | $25.97B | $3.55B | +15.86% |
| 2017 | 2017-12-31 | $22.41B | $2.07B | +10.18% |
| 2016 | 2016-12-31 | $20.34B | −$211.1M | −1.03% |
| 2015 | 2015-12-31 | $20.55B | −$371.7M | −1.78% |
| 2014 | 2014-12-31 | $20.92B | −$231.3M | −1.09% |
| 2013 | 2013-12-31 | $21.15B | −$264.3M | −1.23% |
| 2012 | 2012-12-31 | $21.42B | −$132.9M | −0.62% |
| 2011 | 2011-12-31 | $21.55B | $1.49B | +7.44% |
| 2010 | 2010-12-31 | $20.06B | $759.1M | +3.93% |
| 2009 | 2009-12-31 | $19.30B | $612.4M | +3.28% |
| 2008 | 2008-12-31 | $18.69B | $6.38B | +51.87% |
| 2007 | 2007-12-31 | $12.31B | — | — |
Cme Group quarterly shareholders’ equity
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26.52B | −$1.22B | −4.39% |
| Q1 2026 | 2026-03-31 | $26.62B | −$412.5M | −1.53% |
| Q4 2025 | 2025-12-31 | $28.73B | $2.24B | +8.46% |
| Q3 2025 | 2025-09-30 | $28.19B | −$25.9M | −0.09% |
| Q2 2025 | 2025-06-30 | $27.74B | $103.2M | +0.37% |
| Q1 2025 | 2025-03-31 | $27.03B | −$123.5M | −0.45% |
| Q4 2024 | 2024-12-31 | $26.49B | −$251.0M | −0.94% |
| Q3 2024 | 2024-09-30 | $28.22B | $64.6M | +0.23% |
| Q2 2024 | 2024-06-30 | $27.64B | −$182.0M | −0.65% |
| Q1 2024 | 2024-03-31 | $27.15B | −$230.2M | −0.84% |
| Q4 2023 | 2023-12-31 | $26.74B | −$140.8M | −0.52% |
| Q3 2023 | 2023-09-30 | $28.15B | −$99.2M | −0.35% |
| Q2 2023 | 2023-06-30 | $27.82B | −$183.9M | −0.66% |
| Q1 2023 | 2023-03-31 | $27.38B | −$352.4M | −1.27% |
| Q4 2022 | 2022-12-31 | $26.88B | −$520.6M | −1.90% |
| Q3 2022 | 2022-09-30 | $28.25B | $968.7M | +3.55% |
| Q2 2022 | 2022-06-30 | $28.00B | $1.21B | +4.53% |
| Q1 2022 | 2022-03-31 | $27.74B | $1.18B | +4.45% |
| Q4 2021 | 2021-12-31 | $27.40B | $1.05B | +3.98% |
| Q3 2021 | 2021-09-30 | $27.28B | $271.7M | +1.01% |
| Q2 2021 | 2021-06-30 | $26.79B | −$51.5M | −0.19% |
| Q1 2021 | 2021-03-31 | $26.56B | −$42.8M | −0.16% |
| Q4 2020 | 2020-12-31 | $26.35B | $192.2M | +0.73% |
| Q3 2020 | 2020-09-30 | $27.01B | $197.1M | +0.74% |
| Q2 2020 | 2020-06-30 | $26.84B | $354.0M | +1.34% |
| Q1 2020 | 2020-03-31 | $26.60B | $412.2M | +1.57% |
| Q4 2019 | 2019-12-31 | $26.16B | $194.0M | +0.75% |
| Q3 2019 | 2019-09-30 | $26.81B | $3.52B | +15.10% |
| Q2 2019 | 2019-06-30 | $26.48B | $3.36B | +14.54% |
| Q1 2019 | 2019-03-31 | $26.19B | $3.41B | +14.99% |
| Q4 2018 | 2018-12-31 | $25.97B | $3.55B | +15.86% |
| Q3 2018 | 2018-09-30 | $23.30B | $2.43B | +11.66% |
| Q2 2018 | 2018-06-30 | $23.12B | $2.35B | +11.30% |
| Q1 2018 | 2018-03-31 | $22.77B | $2.22B | +10.79% |
| Q4 2017 | 2017-12-31 | $22.41B | $2.07B | +10.18% |
| Q3 2017 | 2017-09-30 | $20.86B | −$401.0M | −1.89% |
| Q2 2017 | 2017-06-30 | $20.78B | −$297.1M | −1.41% |
| Q1 2017 | 2017-03-31 | $20.55B | −$287.2M | −1.38% |
| Q4 2016 | 2016-12-31 | $20.34B | −$211.1M | −1.03% |
| Q3 2016 | 2016-09-30 | $21.26B | −$111.9M | −0.52% |
| Q2 2016 | 2016-06-30 | $21.07B | −$184.9M | −0.87% |
| Q1 2016 | 2016-03-31 | $20.84B | −$254.1M | −1.20% |
| Q4 2015 | 2015-12-31 | $20.55B | −$371.7M | −1.78% |
| Q3 2015 | 2015-09-30 | $21.38B | −$160.3M | −0.74% |
| Q2 2015 | 2015-06-30 | $21.26B | −$206.6M | −0.96% |
| Q1 2015 | 2015-03-31 | $21.10B | −$209.1M | −0.98% |
| Q4 2014 | 2014-12-31 | $20.92B | −$231.3M | −1.09% |
| Q3 2014 | 2014-09-30 | $21.54B | −$435.2M | −1.98% |
| Q2 2014 | 2014-06-30 | $21.47B | −$383.2M | −1.75% |
| Q1 2014 | 2014-03-31 | $21.30B | −$245.2M | −1.14% |
| Q4 2013 | 2013-12-31 | $21.15B | −$264.3M | −1.23% |
| Q3 2013 | 2013-09-30 | $21.97B | $263.5M | +1.21% |
| Q2 2013 | 2013-06-30 | $21.85B | $228.6M | +1.06% |
| Q1 2013 | 2013-03-31 | $21.55B | $700,000 | +0.00% |
| Q4 2012 | 2012-12-31 | $21.42B | −$132.9M | −0.62% |
| Q3 2012 | 2012-09-30 | $21.71B | $844.5M | +4.05% |
| Q2 2012 | 2012-06-30 | $21.62B | $717.5M | +3.43% |
| Q1 2012 | 2012-03-31 | $21.55B | $761.6M | +3.66% |
| Q4 2011 | 2011-12-31 | $21.55B | $1.49B | +7.44% |
| Q3 2011 | 2011-09-30 | $20.86B | $963.5M | +4.84% |
| Q2 2011 | 2011-06-30 | $20.90B | $1.52B | +7.84% |
| Q1 2011 | 2011-03-31 | $20.79B | $1.60B | +8.33% |
| Q4 2010 | 2010-12-31 | $20.06B | $759.1M | +3.93% |
| Q3 2010 | 2010-09-30 | $19.90B | $770.5M | +4.03% |
| Q2 2010 | 2010-06-30 | $19.38B | $402.2M | +2.12% |
| Q1 2010 | 2010-03-31 | $19.19B | — | — |
| Q4 2009 | 2009-12-31 | $19.30B | $612.4M | +3.28% |
| Q3 2009 | 2009-09-30 | $19.13B | — | — |
| Q2 2009 | 2009-06-30 | $18.98B | — | — |
| Q4 2008 | 2008-12-31 | $18.69B | — | — |
Cme Group shareholders’ equity trends
Over the last five fiscal years, Cme Group's shareholders’ equity increased from $26.35B to $28.73B, a change of $2.38B. The latest reported quarter, Q2 2026, shows $26.52B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...